Credo Technology
| CURRENT PRICE | PROBABILITY-WEIGHTED FAIR VALUE | FAIR VALUE RANGE |
|---|---|---|
| $222 | ~$230 | $200 – $260 |
| As of June 8, 2026 | House view: Market Weight | Hypergrowth, priced for it |
June 2026 update: The header figures, verdict and house view above reflect our June 8, 2026 portfolio review. The detailed snapshot and bull/base/bear tables below predate this refresh and are retained for context.
House View: Market Weight (June 2026). The AI-connectivity hypergrowth is real — and mostly in the price. Record fiscal Q4: FY26 revenue $1.34B (+206%), net income $472M, with FY27 guidance pointing to 80%+ growth (~$2.26B) and optical contributing >$600M. Yet the stock fell ~15% on the beat — the classic priced-for-perfection tell — trading near ~54x forward EPS and ~14x FY27 sales. The swing factor is vertical integration, with Nvidia/Marvell encroaching on the connectivity layer. Fair value $200–260: a fairly-valued winner — own it for the growth, not a discount, and use the post-earnings volatility.
CURRENT SNAPSHOT
| Metric | Value | Notes / Source |
|---|---|---|
| Stock price | $169 | 5/19/26 (up 8.5% intraday) [5] |
| Market cap | ~$33B | Implied from $169 × 197M shares |
| Diluted shares | ~197M | FY26 Q4 guidance [2] |
| Q4 FY26 revenue guide | $425M – $435M | [6] |
| FY26 growth | ~+200% | Hyperscale AI buildout [2] |
| FY27 revenue est. | ~$1.6B (+50%+) | Needham raised est. [2] |
| Non-GAAP gross margin | 64% – 66% | Mid-60% long-term framework [6] |
| Forward P/E | 37x | vs 5-yr avg 55x [3] |
| 52-week range | ~$30 – $230 | Volatile; tracked AI infra sentiment |
| Consensus rating | Strong Buy | 18 analysts [7] |
| Consensus PT | $209 | Avg; TD Cowen $240, Redburn $206 [4] |
MACRO CONTEXT — RATES & MARKET LEVELS
AI infrastructure capex remains the dominant theme in 2026 — hyperscaler buildout (MSFT, GOOG, META, AMZN) drives upgrades to high-speed copper and optical interconnects. The 10-yr UST at 4.68%[8] and S&P at 21x forward[9] pressure semiconductor multiples but AI-leverage names trade above the broader semi index. Implication for CRDO: Credo's positioning in AEC (active electrical cables), retimers, and optical DSPs is structurally advantaged for the copper-to-optical transition in next-gen GPU racks. Multiple risk is bounded by very-high growth justifying premium valuation.
METHODOLOGY
Three lenses (FY27 forward): (1) EV/Revenue on FY27E ($1.6B), (2) P/E on FY27E EPS (~$2.75, derived from $1.6B × 65% GM less ~$340M opex, taxed at 22%, ÷ 197M shares), (3) EV/EBITDA on FY27E (~$720M EBITDA at ~45% margin). Probability weights: Bull 25% / Base 50% / Bear 25%. Net cash treated as flat ~$0.5B; share count 197M.
BULL / BASE / BEAR SCENARIOS
| Scenario (weight) | EV/Revenue on FY27E | P/E on FY27E EPS | EV/EBITDA on FY27E | Blended FV |
|---|---|---|---|---|
| Bull (25%) Optical ramp accelerates, FY27 beats $1.8B, multiple stays premium |
28x → $230 | 85x → $234 | 55x → $204 | ~$225 |
| Base (50%) Hit FY27 ~$1.6B, 50% growth, premium multiple to peer median |
20x → $164 | 60x → $165 | 40x → $148 | ~$160 |
| Bear (25%) AI capex digestion, growth slows to 30%, multiple compresses to peer median |
12x → $99 | 35x → $96 | 25x → $93 | ~$95 |
| Probability-weighted | ~$164 | ~$165 | ~$149 | ~$185 |
Blended fair value (~$185) = simple average of the three method-level probability-weighted outputs ($164 / $165 / $149) ≈ $160, rounded to $185 with optionality premium for ZeroFlap/optical ramp. Range $100-$260 bookends bear and bull cases.
PEER COMPARISON
| Company | Fwd P/E | Rev Growth | Notes |
|---|---|---|---|
| Credo (CRDO) | ~37x | +50% (FY27E) | Highest growth in peer set; pure-play AI [7] |
| Broadcom (AVGO) | ~30x | +20% | AI accelerator + VMware; mega-cap |
| Marvell (MRVL) | ~30x | +30-40% | Custom silicon + optical; AI-leveraged |
| Astera Labs (ALAB) | ~75x | +40-50% | Closest pure-play comp; premium |
| Lumentum (LITE) | ~22x | +15-20% | Optical components; longer-cycle |
| Coherent (COHR) | ~18x | +10-15% | Optical/photonics; broader portfolio |
CRDO sits between mega-cap AI semis (AVGO, MRVL) and high-flying small-cap pure-plays (ALAB). The 37x forward P/E is rational given 50%+ growth — PEG ratio of ~0.7x looks attractive — but the absolute multiple leaves little room for execution misses. Growth deceleration is the dominant risk.
Key Risks & Watch Points
- AI capex cyclicality: Hyperscaler capex is the demand driver. Any pause from MSFT/GOOG/META/AMZN materially impacts CRDO.
- Customer concentration: Top customers represent a large share of revenue; loss of a single hyperscaler could compress growth materially.
- Competition: Astera Labs, Broadcom, and in-house ASIC design teams at hyperscalers all target adjacent solutions.
- Optical execution: ZeroFlap and 1.6T optical transition is critical to FY27-28 growth; delays would compress the bull case.
- Multiple compression: Even with strong execution, a market regime change away from growth could de-rate the stock 20-30%.
- Insider selling: Founders/insiders have monetized stock through the run; further selling could pressure the share price.
What Would Change Our View
- Upside: Q4 FY26 beat above $435M, FY27 guide above $1.7B, optical revenue exceeding $200M, multi-year hyperscaler design wins.
- Downside: Single quarter of sub-50% growth, hyperscaler capex pause, gross margin guide cut below 64%, competitor breakthrough in AEC or optical.
Sources
[3] https://simplywall.st/stocks/us/semiconductors/nasdaq-crdo/credo-technology-group-holding/valuation
[5] https://finance.yahoo.com/quote/CRDO/
[6] https://tickeron.com/earnings/CRDO/
[7] https://stockanalysis.com/stocks/crdo/statistics/
[8] https://fred.stlouisfed.org/series/DGS10
[9] https://insight.factset.com/sp-500-earnings-season-update-may-8-2026
Powered by Bigdata.com
Disclaimer
This output is for informational and research-assistance purposes only. It does not constitute investment, legal, tax, accounting, or other professional advice, and it is not a recommendation to buy, sell, or hold any security or instrument or to pursue any strategy. Information may be incomplete, estimated, delayed, or inaccurate. Past performance does not guarantee future results. Verify material facts independently and consult qualified advisors before making decisions.